The results of serum biomarker detection showed that the serum levels of KL-6, CEA, CA125, and CA153 in pSS-ILD patients were significantly higher than those in the non-ILD group and healthy control group (p < 0.05). This evidence concerns the gene CEACAM5 and interstitial lung disease.